LTR Pharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	31.81	3.1	1.73	1.91	0.15
Cash & Short-Term Investments	31.81	3.1	1.73	1.91	0.15
Cash Growth	925.31%	79.46%	-9.56%	1205.48%	-
Accounts Receivable	0	-	-	-	-
Other Receivables	0.24	0.27	0.06	0.04	-
Receivables	0.25	0.27	0.06	0.04	-
Inventory	0.02	-	-	-	-
Total Current Assets	32.07	3.37	1.79	1.95	0.15
Property, Plant & Equipment	0.01	0	-	-	-
Long-Term Investments	0.12	-	-	-	-
Other Long-Term Assets	-	-	-	-	0
Total Assets	32.21	3.37	2.09	2.25	0.42
Accounts Payable	0.11	0.24	0.01	0.47	0
Accrued Expenses	0.5	0.13	0.01	0.01	0
Short-Term Debt	-	-	-	-	0.36
Other Current Liabilities	0.1	0.06	-	-	0.1
Total Current Liabilities	0.7	0.43	0.02	0.48	0.46
Total Liabilities	0.7	0.43	0.02	0.48	0.46
Common Stock	44.11	10.74	4.53	2.79	-
Retained Earnings	-15.07	-9.48	-2.52	-1.07	-0.04
Comprehensive Income & Other	2.47	1.67	0.07	0.04	-
Shareholders' Equity	31.51	2.94	2.07	1.77	-0.04
Total Liabilities & Equity	32.21	3.37	2.09	2.25	0.42
Total Debt	-	-	-	-	0.36
Net Cash (Debt)	31.81	3.1	1.73	1.91	-0.21
Net Cash Growth	925.31%	79.46%	-9.56%	-	-
Net Cash Per Share	0.19	0.02	0.01	-	-
Filing Date Shares Outstanding	180.98	153.8	414.9	-	-
Total Common Shares Outstanding	180.98	139.42	414.9	-	-
Working Capital	31.37	2.94	1.77	1.48	-0.32
Book Value Per Share	0.17	0.02	0.00	-	-
Tangible Book Value	31.51	2.94	2.07	1.77	-0.04
Tangible Book Value Per Share	0.17	0.02	0.00	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.